The IPO will comprise 32,500,000 shares with a face value of Rs. 2 each, potentially raising funds of up to ₹351 crore for Aeroflex Industries Limited . Let’s delve into the details of their IPO set to hit the market in August 2023.

About Aeroflex Industries Limited 

Established in 1993, Aeroflex Industries Limited, formerly Suyog Intermediates Private Limited, specializes in manufacturing eco-friendly metallic flexible flow solutions. Their extensive product range encompasses braided, unbraided, solar, gas, and vacuum hoses, interlock hoses, hose assemblies, expansion bellows, EGR tubes, exhaust connectors, and more. With over 1,700 Product SKUs, their portfolio is diverse and comprehensive.

Aeroflex operates from a state-of-the-art facility spanning 3,59,528 square feet in Taloja, Navi Mumbai. The facility holds certifications for pressure equipment, quality, environmental management, and occupational health & safety. Serving a wide clientele including distributors, fabricators, MROs, and OEMs across various industries, Aeroflex achieved a revenue of Rs. 2694.78 Lakhs in Fiscal 2023 and Rs. 2409.92 Million in Fiscal 2022.

Aeroflex Industries Limited  IPO Issue Details

Purpose of the Issue

The company has outlined its plans for the net proceeds as follows:

• Repayment and/or prepayment of secured borrowings,
• Meeting working capital needs, and
• General corporate purposes, including unidentified inorganic acquisitions.

Aeroflex Industries Limited — Company Contact Details

• Registered & Corporate Office: Plot No. 41, 42/13, 42/14 & 42/18, near Taloja MIDC, Village Chal, Behind IGPL, Panvel, Navi Mumbai – 410 208
• Telephone: +91 22 61467100
• Website: https://www.aeroflexindia.com/ 

Aeroflex Industries Limited IPO – Lead Managers of the Issue

Pantomath Capital Advisors Pvt Ltd

• Office Address: 108, Madhava Premises CHS Ltd, Bandra Kurla Complex, Bandra East, Mumbai 400051
• Telephone:  +91 22 2659 8687 / 91
• Email: [email protected]  

Aeroflex Industries Limited IPO – Registrar of the Issue

Link Intime India Private Ltd

• Telephone: +91-22-4918 6270
• Email: [email protected] 
• Website: https://linkintime.co.in 

Aeroflex Industries Limited IPO Issue Prospectus

Click here to read the Final Prospectus of this IPO Issue.

Disclaimer: Investingly just provides basic information as update about the issues. Investingly never gives advices or recommendations to anyone. Investments into securities are subject to market risk. Please read the offer and issue documents carefully before investing. It is also advised to consult your financial advisor for necessary suggestions.

The post Aeroflex Industries IPO – Issue Date, Issue Price, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The NFO will be open for subscription from August 16th, 2023 and will end on August 30th, 2023. Within five Business Days following the date of allotment, the Schemes will reopen for continuous sale and repurchase. Subscriptions can be made starting at Rs. 1000 and in multiples of Rs. 1/-. Both a Regular Plan and a Direct Plan are available.

About Union Mutual Fund

Union Mutual Fund, backed by Union Bank of India, has been a significant force in India’s asset management sector for over a decade. Their vision is to empower investors to achieve sustainable prosperity through responsible capital market investments.

Founded on December 30, 2009, the AMC leveraged Union Bank of India’s substantial client base to establish a robust asset management portfolio. Initially formed in partnership with Belgium’s KBC Asset Management NV, it was known as Union KBC Mutual Fund, with Union Bank holding the majority stake.

The collaboration with KBC ended in 2016, leading to Union Bank’s complete ownership. In 2017, Japan’s Dai-ichi Life acquired a 39.62% stake, further strengthening the company. While the AMC’s structure remained unchanged, Dai-ichi appointed a nominee to its Board of Directors.

Union Innovation & Opportunities Fund – NFO Detail

Union Innovation & Opportunities Fund NFO – Scheme Objective

The Investment Objective of the Scheme is to achieve long term capital appreciation by investing predominantly in equity and equity related securities of Innovative Companies. 

Union Innovation & Opportunities Fund NFO – Who Can Invest?

This product is suitable for investors who are seeking*:

• Long term capital appreciation.
• Investment predominantly in equity and equity related securities of Innovative Companies.

How Will the Scheme Allocate Its Asset

• 80-100% in Equity and Equity related Instruments of innovative companies.
• 0-20% in Equity and Equity related Instruments of other than above companies.
• 0-20% in Debt and Money Market Instruments.
• 0-10% in Units issued by REITs and InvITs.

Where Will the Scheme Invest?

The corpus of the Scheme will be invested in a portfolio of predominantly Equity and Equity Related Instruments of Innovative Companies. The Scheme shall also invest in Equity and Equity Related Instruments of other than above companies and further also in Debt and Money Market Instruments, units issued by REITs and InvITs and schemes of mutual funds. Further, pending deployment of funds of the Scheme in securities in terms of the investment objective, and for margin purposes, the AMC may park the funds of the Scheme in short term deposits of scheduled commercial banks, subject to the guidelines issued by SEBI from time to time. The securities/ instruments in which the Scheme shall invest include but are not limited to the following: 

• Investment in Equity and Equity linked Instruments: Equity related securities include, but are not limited to:

i. Equity Warrants and Convertible Instruments.

ii. Fully Convertible debentures, Debentures, Partly Convertible Debentures, unlisted securities,

initial public offerings, private placements etc.

iii. Equity Derivatives. (Futures and Options)

iv. Any other securities / instruments as may be permitted by SEBI from time to time.

• Investment in Debt and Money Market Instruments:

1. Certificate of Deposit (CD)

2. Tri-party Repo in Government Securities

3. Commercial Paper (CP)

4. Reverse Repo

5. Treasury Bill (T-Bill)

6. Securities created and issued by the Central and State Governments

7. Non-convertible debentures and bonds

8. Floating rate debt instruments 

9. Debt derivative instruments

Union Innovation & Opportunities Fund NFO – SID (Scheme Information Document)

Please click here to read the SID (Scheme Information Document) of this NFO scheme.

How to Invest?

Visit this page on the AMC website for further detail and investment.

Disclaimer: This post is just information about the scheme. It does not give any advice or recommendation. Mutual Fund investments are subject to market risk. Please read the offer document carefully before investing.

The post Union Innovation & Opportunities Fund – NFO Dates, Scheme Features appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

About NJ Mutual Fund

NJ Asset Management Private Limited is a reputable player in India’s financial services and wealth management sector, operating under NJ India Invest Pvt. Ltd. Established in 1994, NJ India Invest was a pioneer in finance management, evolving to address the changing financial landscape.

Under the NJ group, led by Mr. Niraj Choksi and Mr. Jignesh Desai, the business extends beyond product distribution to include loans, insurance, asset management, and offshore fund distribution. NJ Mutual Fund, a part of this group, manages mutual fund assets of Rs. 1,22,477 crore as of January 31, 2022.

NJ Mutual Fund employs “Rule-based Active Investment,” uniting financial expertise and technology to select stocks, allocate assets, and predict returns. This data-driven approach reduces bias and benefits both investors and partners.Their specialized research team ensures value and convenience for clients through portfolio management and mutual fund analysis, adhering to SEBI regulations.

NJ Flexi Cap Fund – NFO Detail

NJ Flexi Cap Fund NFO – Scheme Objective

The investment objective of the Scheme is to generate long term capital appreciation by investing in equity and equity related instruments across market capitalizations.

NJ Flexi Cap Fund NFO – Who Can Invest?

This product is suitable for investors who are seeking*:

• Long term capital appreciation.
• Investment in equity and equity related securities of companies.

How Will the Scheme Allocate Its Asset

• 80-100% in Equity and Equity related Instruments.
• 0-20% in Specified Debt Securities,units of mutual funds, cash and cash equivalents.

Where Will the Scheme Invest?

The scheme will predominantly invest in equity and equity related securities. The Scheme may also invest a certain proportion of its corpus in debt and money market securities of India. The fund may invest in:

• Equity and equity related securities including preference shares and warrants.
• Equity Related Instruments,being securities which give the holder of the security right to receive Equity Shares on preagreed terms. It includes convertible/optionally convertible/compulsorily convertible preference shares,share warrants and other security which has equity component embedded in it .
• Equity Derivatives, which are financial instruments, generally traded on the stock exchange,the price of which is directly dependent upon(i.e.,“derived from”) the value of equity shares or equity indices. Derivatives involve the trading of rights or obligations based on the underlying, but do not directly transfer property.
• TREPS, Repo, Treasury bills, cash and cash equivalents.
• Government Securities Issued By(central and state governments)and other securities issued by RBI from time to time.
• Units of Mutual funds including ETFs as may be permitted by  SEBI regulation.
• Fixed Deposit as permitted under SEBI Regulations From time to time.
• Any other instruments may be permitted byRBI /SEBI /such other Regulatory Authority(ies) from time to time. 

NJ Flexi Cap Fund NFO – SID (Scheme Information Document)

Please click here to read the SID (Scheme Information Document) of this NFO scheme.

How to Invest?

Visit this page on the AMC website for further detail and investment.

Disclaimer: This post is just information about the scheme. It does not give any advice or recommendation. Mutual Fund investments are subject to market risk. Please read the offer document carefully before investing.

The post NJ Flexi Cap Fund – NFO Dates, Scheme Features appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The IPO will comprise 5,140,000 shares with a face value of Rs. 10 each, potentially raising funds of up to ₹26.73 crore for Crop Life Science Limited. Let’s delve into the details of their IPO set to hit the market in August 2023.

About Crop Life Science Limited 

Incorporated in 2006, Crop Life Science Limited specializes in manufacturing, distributing, and marketing agrochemical formulations. Their product range covers agricultural chemicals like Micro fertilizers, and pesticides including Insecticides, Fungicides, Herbicides, and Weedicides. With a manufacturing unit in GIDC Ankleshwar, Gujarat, spanning 5831.10 Square Meters, the company exports to various countries including Indonesia, Bangladesh, and Vietnam.

Crop Life Science’s products are registered with the Central Insecticides Board (CIB) and approved by the Directorate of Agriculture, Government of Gujarat, and the Gujarat Pollution Control Board (GPCB). Their diverse portfolio comprises more than 85 agro-chemical products.

Crop Life Science Limited IPO Issue Details

Purpose of the Issue

The company has outlined its plans for the net proceeds as follows:

• To meet long-term working capital requirements.
• General corporate purposes.
• Meeting Public Issue Expenses.

Crop Life Science Limited  — Company Contact Details

• Registered & Corporate Office: 209, Near Judges Bunglow Cross Road, Bodakdev, Ahmedabad – 380015
• Telephone: 079-40373967
• Website: https://croplifescience.com 

Crop Life Science Limited  IPO – Lead Managers of the Issue

Interactive Financial Services Ltd 

• Office Address: A – 1006, Premium House, B/h Handloom House, Ashram Road, Ahmedabad – 380009
• Telephone:+91-79-2658 1240 
• Email:  [email protected]  

Crop Life Science Limited IPO – Registrar of the Issue

Purva Sharegistry India Pvt Ltd

• Telephone: +91-022-23018261/ 23016761
• Email: [email protected] 
• Website: https://www.purvashare.com 

Crop Life Science Limited  IPO Issue Prospectus

Click here to read the Final Prospectus of this IPO Issue.

Disclaimer: Investingly just provides basic information as update about the issues. Investingly never gives advices or recommendations to anyone. Investments into securities are subject to market risk. Please read the offer and issue documents carefully before investing. It is also advised to consult your financial advisor for necessary suggestions.

The post Crop Life Science IPO – Issue Date, Issue Price, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The IPO will comprise 5,696,000 shares with a face value of Rs. 10 each, potentially raising funds of up to ₹42.72 crore for Bondada Engineering Limited. Let’s delve into the details of their IPO set to hit the market in August 2023.

About Bondada Engineering Limited 

Incorporated in 2012, Bondada Engineering Limited offers EPC and O&M services to the telecom and solar energy sectors. Their offerings encompass passive telecom infrastructure services, including telecom tower construction, operation, and maintenance, optical fiber cable laying, and telecom infrastructure supplies. With over 11,600 installations, they serve major telecom companies in India.

Additionally, they provide O&M services to telecom companies, covering preventive and corrective maintenance of passive infrastructure and equipment, power systems, surveillance, and more. Bondada’s manufacturing unit in Telangana has an installation capacity of ~12 thousand MTPA for tower fabrication. The company employs over 550 professionals.

Bondada Engineering Limited IPO Issue Details

Purpose of the Issue

The company has outlined its plans for the net proceeds as follows:

• To meet long-term working capital requirements.
• General corporate purposes.

Bondada Engineering Limited  — Company Contact Details

• Registered & Corporate Office: 1-1-27/37, Ashok Manoj Nagar Kapra, Hyderabad – 500062
• Telephone:+91 72070 34662 
• Website: https://bondada.net/ 

Bondada Engineering Limited  IPO – Lead Managers of the Issue

Vivro Financial Services Private Limited

• Office Address: 1st Floor, Manu Mansion 16/18, Shahid Bhagatsingh Road Opp. Old Custom House, Fort, Mumbai – 400 023
• Telephone:  022-2265 7364
• Email: [email protected] 

Bondada Engineering Limited IPO – Registrar of the Issue

Kfin Technologies Limited

• Telephone: 04067162222, 04079611000
• Email: [email protected] 
• Website:   https://kosmic.kfintech.com 

Bondada Engineering Limited  IPO Issue Prospectus

Click here to read the Final Prospectus of this IPO Issue.

Disclaimer: Investingly just provides basic information as update about the issues. Investingly never gives advices or recommendations to anyone. Investments into securities are subject to market risk. Please read the offer and issue documents carefully before investing. It is also advised to consult your financial advisor for necessary suggestions.

The post Bondada Engineering IPO – Issue Date, Issue Price, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The IPO will comprise 424,000 shares with a face value of Rs. 10 each, potentially raising funds of up to ₹2.03 crore for Shoora Designs Limited. Let’s delve into the details of their IPO set to hit the market in August 2023.

About Shoora Designs Limited

Incorporated in 2021, Shoora Designs Limited specializes in manufacturing and trading diamonds and jewelry. Their focus is on natural diamonds and jewelry, particularly Natural Lab Grown Diamond and Jewelry.

Shoora sources natural diamonds from suppliers, while cleaving, cutting, and polishing services are outsourced locally in Surat. Rough diamond planning is managed in-house. Mainly catering to wholesalers and retailers in Surat, Gujarat, and Mumbai, the company’s jewelry is available both offline and online. For the nine months ended March 31, 2023, Shoora Designs reported revenue of Rs. 105.58 lakhs, and Rs. 162.58 lakhs for the Fiscal Year ended March 31, 2022.

Shoora DesignsLimited IPO Issue Details

Purpose of the Issue

The company has outlined its plans for the net proceeds as follows:

• Meeting working capital requirements.
• General corporate purposes.

Shoora Designs Limited — Company Contact Details

• Registered & Corporate Office: Diamond Apartments Co-op Housing Society, LT H No. 7/3388/A, 6th floor, C/1, 601, Haththupura char rasta, Surat – 395003
• Telephone: +91 9004746705 
• Website: https://www.shooradesigns.com/ 

Shoora Designs Limited IPO – Lead Managers of the Issue

Swaraj shares and securities private limited 

• Office Address: 304, A Wing, 215 Atrium Near Courtyard Marriot, Andheri Kurla Road, Andheri East, Mumbai – 400093, Maharashtra, India
• Telephone: +912269649973
• Email: [email protected]  

Shoora Designs Limited IPO – Registrar of the Issue

Kfin Technologies Limited

• Telephone: 04067162222, 04079611000
• Email: [email protected] 
• Website:   https://kosmic.kfintech.com 

Shoora Designs Limited IPO Issue Prospectus

Click here to read the Final Prospectus of this IPO Issue.

Disclaimer: Investingly just provides basic information as update about the issues. Investingly never gives advices or recommendations to anyone. Investments into securities are subject to market risk. Please read the offer and issue documents carefully before investing. It is also advised to consult your financial advisor for necessary suggestions.

The post Shoora Designs IPO – Issue Date, Issue Price, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

Five separate series of NCDs are being issued, with terms varying 18 and 24 months and coupons ranging from 9.57 % p.a. to 10.50 % p.a. The maximum amount the company hopes to raise is Rs 250 crore with a Face value of Rs. 1000 each NCD and a minimum lot size of 10 NCD. The NCDs have a redeemable and secure nature. Let’s investigate more details and get into greater detail about this NCD issue.

About Vivriti Capital Limited

Established in 2017, Vivriti Capital Limited extends lending solutions to mid-market enterprises across India. The company holds RBI registration as a significant non-deposit-taking non-banking financial company (NBFC-NDSI).

Vivriti Capital offers a spectrum of financial products including term loans, working capital demand loans, co-lending partnerships, securitization, supply chain finance, and investment in bonds and commercial paper. These offerings serve entities without easy access to banking finance due to either unrated status or limited ratings, primarily in urban/semi-urban areas. Their clientele spans various sectors such as healthcare, pharma, logistics, manufacturing, and more. As of March 31, 2023, Vivriti Capital held outstanding loan assets of ₹450,873.24 lakh, investments in bonds, securitizations, and commercial paper of ₹132,706.77 lakhs, and an AUM of ₹583,580.01 lakhs.

With credit ratings of A (stable outlook) by ICRA Limited and A (positive outlook) by CARE Ratings, Vivriti Capital operates across multiple states including Tamil Nadu, Maharashtra, Karnataka, Rajasthan, and Delhi.

Vivriti Capital Limited NCD 2023 – Issue Details

Vivriti Capital Limited NCD 2023 – Objects of the Issue

The proceeds from the Issue will be used as follows, as stated by the company:

• Onward lending, financing, and repayment of interest and principal of existing borrowings of the company.
• General Corporate Purposes.

Power Finance Corporation Limited NCD Issue Ratings

This NCD issue has been rated ICRA A (Stable) by ICRA Limited and CARE A+ by CARE Ratings Limited.

Vivriti Capital Limited – Company Contact Details

• Address: Prestige Zackria Metropolitan No. 200/1-8, 2nd Floor, Block -1, Annasalai, Chennai 600 002
• Telephone: +91 44 4007 4800
• Website:  https://www.vivriticapital.com/ 

Vivriti Capital Limited NCD 2023 – Lead Manager of the Issue

The lead manager for this NCD issue is Jm Financial Limited. 

Vivriti Capital Limited NCD 2023 – Registrar of the Issue

The registrar of this NCD issue is Integrated Registry Management Services Private Limited.

Vivriti Capital Limited NCD 2023 – Debenture Trustee

The trustee of this debenture issued by Vivriti Capital Limited is Catalyst Trusteeship Limited.

Issue Documents

Please click here to read the final issue prospectus for detailed information on Vivriti Capital Limited NCD issue 2023.

Disclaimer: This post is just information about the scheme. It does not give any advice or recommendation. Investment in securities is subject to market risk. Please read the offer document carefully before investing. It is also advised to consult your financial advisor of necessary suggestions.

The post Vivriti Capital Limited NCD 2023 – Coupon Rate, Issue Dates, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The New Fund Offering (NFO) is open for subscription from August 10th to August 24th, 2023. Within five Business Days of allotment, the Schemes will reopen for continuous sale and repurchase. Subscriptions start at Rs. 5000 and multiples of Rs. 1/-. Both Regular and Direct Plans are accessible.

About HSBC Mutual Fund

Part of HSBC Securities and Capital Markets (India) Private Limited, HSBC Mutual Funds is a leading AMC in India’s investment market. Backed by HSBC, the 7th largest global bank, it provides top-tier investment options and services to investors nationwide. HSBC Mutual Fund serves over 1 million customers through 1000+ offices across India. With a corpus of Rs. 12,637.24 Crore (2022), it offers 103 diverse schemes spanning equity, debt, and add-on funds.

Globally, HSBC boasts 100 million active customers, excluding Polar regions, with £102.7 billion market cap (2018). HSBC’s India operations are a key asset, and it has expansion plans for South East Asia. Aligned with regulations, HSBC Mutual Fund operates under Indian Trusts Act (1882) and holds SEBI registration number MF/046/02/5.

HSBC Consumption Fund – NFO Detail

HSBC Consumption Fund NFO – Scheme Objective

The investment objective of the Fund is to generate long-term capital growth from an actively managed portfolio of equity and equity related securities of companies engaged in or expected to benefit from consumption and consumption related activities.

HSBC Consumption Fund NFO – Who Can Invest?

This product is suitable for investors who are seeking*:

• To create wealth over long-term
• Investment predominantly in equity and equity related securities of companies engaged in or expected to benefit from consumption and consumption related activities.

How Will the Scheme Allocate Its Asset

• 80-100% in Equities & Equity related securities of companies engaged in or expected to benefit from consumption and consumption related activities.
• 0-20% in Equity and equity related securities of companies other than consumption and consumption related activities.
• 0-20% in Debt Securities & Money Market instruments (including Cash & cash equivalents, units of Liquid and Overnight mutual funds).
• 0-10% in Units of REITs and InvITs.

Where Will the Scheme Invest?

The aim of the Scheme is to generate long-term capital growth from an actively managed portfolio of equity and equity related securities of companies engaged in or expected to benefit from consumption and consumption related activities. Subject to the Regulations and other prevailing laws as applicable, the corpus of the Scheme can be invested in any (but not exclusively) of the following securities:

• Equity and equity related securities including convertible bonds and debentures and warrants carrying the right to obtain equity shares.  
• ADRs / GDRs issued by the Indian companies, subject to the guidelines issued by the Reserve Bank of India and Securities and Exchange Board of India.  
• Units of REITs and InvITs.
• Foreign securities including overseas funds and Exchange Traded Funds as may be permitted by SEBI / RBI.  
• Liquid and Overnight mutual funds.  
• Stock index futures and such other derivative instruments permitted by SEBI / RBI.  
• Securities issued / guaranteed by the Central, State and local governments (including but not limited to coupon bearing bonds, zero coupon bonds and treasury bills). 
• Indian Depository Receipts (IDR) issued by foreign companies, subject to the guidelines issued by RBI and SEBI.
• Debt obligations of domestic government agencies and statutory bodies, which may or may not carry a Central / State Government guarantee.
• Corporate debt (of both public and private sector undertakings).
• Debt obligations of banks (both public and private sector) and financial institutions.
• Money market instruments permitted by SEBI and / or RBI, having residual maturities of up to 1 year.  
• Certificate of Deposits (CDs)  
• Commercial Paper (CPs)  
• Bills of Exchange / Promissory Notes  
• Securitised Debt  
• TREPS & reverse repos  
• Floating Rate Instruments  
• Repurchase and reverse repurchase obligations in securities  
• Repo in Corporate bonds  
• The non-convertible part of convertible securities  
• Any other domestic fixed income securities

HSBC Consumption Fund NFO – SID (Scheme Information Document)

Please click here to read the SID (Scheme Information Document) of this NFO scheme.

How to Invest?

Visit this page on the AMC website for further detail and investment.

Disclaimer: This post is just information about the scheme. It does not give any advice or recommendation. Mutual Fund investments are subject to market risk. Please read the offer document carefully before investing.

The post HSBC Consumption Fund – NFO Dates, Scheme Features appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

The IPO will comprise 9,220,000 shares with a face value of Rs. 10 each, potentially raising funds of up to ₹153.05 crore for Pyramid Technoplast Limited. Let’s delve into the details of their IPO set to hit the market in August 2023.

About Pyramid Technoplast Limited

Incorporated in 1997, Pyramid Technoplast Limited specializes in producing polymer-based molded products, particularly Polymer Drums, vital for packaging needs of chemical, agrochemical, specialty chemical, and pharmaceutical industries.

The company manufactures polymer-based bulk packaging drums, Intermediate Bulk Containers (IBC), and MS Drums for chemicals, agrochemicals, and specialty chemicals. Operating six units, with four in Bharuch, Gujarat, and two in Silvassa, Dadra and Nagar Haveli, they have an installed capacity of 20,612 MTPA for Polymer Drums, 12,820 MTPA for IBC, and 6,200 MTPA for MS Drums. An upcoming seventh unit in Bharuch is in progress.

Pyramid Technoplast IPO Issue Details

Purpose of the Issue

The company plans to allocate the net proceeds from the issue to the following objectives:

• Repayment and/or pre-payment, either in full or partially, of specific outstanding borrowings.
• Financing the company’s working capital needs.
• Catering to general corporate purposes.

Pyramid Technoplast Limited — Company Contact Details

• Registered & Corporate Office: Office No.2, 2nd Floor, Shah Trade Centre, Rani Sati Marg, Near W.E Highway, Malad (East), Mumbai – 400 097
• Telephone:  +91 22 4276 1547
• Website: https://pyramidtechnoplast.com/ 

Pyramid Technoplast IPO – Lead Managers of the Issue

Pnb Investment Services Ltd 

• Office Address: 11th Floor, Dalamal House, Nariman Point, Mumbai
• Telephone: +91-22-4347 4030
• Email: [email protected] 

First Overseas Capital Limited 

• Office Address: 1-2, Bhupen Chambers Ground Flr, Dalal Street, Mumbai – 400001
• Telephone: +91 22 4050 9900
• Email:  [email protected] 

Pyramid Technoplast IPO – Registrar of the Issue

Bigshare Services Pvt Ltd

• Telephone: +91-22-6263 8200
• Email: [email protected] 
• Website:  https://bigshareonline.com/ 

Pyramid Technoplast Limited IPO Issue Prospectus

Click here to read the Final Prospectus of this IPO Issue.

Disclaimer: Investingly just provides basic information as update about the issues. Investingly never gives advices or recommendations to anyone. Investments into securities are subject to market risk. Please read the offer and issue documents carefully before investing. It is also advised to consult your financial advisor for necessary suggestions.

The post Pyramid Technoplast IPO – Issue Date, Issue Price, Issue Prospectus appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.

Incorporated in 1984, Aarti Drugs Limited specializes in the production of specialty chemicals and bulk drugs. Their extensive range comprises over 40 products, including bulk actives, key intermediates, and specialty chemicals. These products cover therapeutic groups such as antibiotic, anti-protozoal, anti-inflammatory, anti-fungal, anti-diabetic, cardio-protectant, vitamins, anti-arthritis, and sedatives, addressing critical and lifestyle-related illnesses.

Aarti Drugs operates nine manufacturing units in Tarapur (Maharashtra) and two units in Sarigam (Gujarat), most of which are GMP certified. The company exports to more than 100 countries, holding approvals from multiple authorities like WHO-GMP, ACCREDITATION from JAPAN, IDL China, ANVISA, TGA Australia, COFEPRIS, and COS.

In recent years, Aarti Drugs achieved total revenues of ₹2,71,824.75 lakhs (2023), ₹2,49,996.17 lakhs (2022), and ₹2,15,930.50 lakhs (2021).

Aarti Drugs Limited Buyback 2023 – Offer Details

Aarti Drugs Limited Buyback 2023 – Necessity of the Buyback

The Company’s proposed Buyback serves the following purposes:

1. Returning excess cash to Equity Shareholders.
2. Enhancing return on equity and earnings per share through cash distribution and reduction of equity base, thereby increasing shareholder value over the long term.
3. Offering Equity Shareholders a choice: sell shares for cash or retain shares and enjoy a higher percentage ownership after the Buyback, without additional investment.
4. Implemented through a tender offer as per Buyback Regulations, the Buyback includes a minimum 15% reservation for Small Shareholders. Additionally, a higher number of shares will be allocated based on entitlement or 15% of shares to be bought back, specifically reserved for Small Shareholders. This approach aims to benefit a significant number of public shareholders, classified as Small Shareholders.

Aarti Drugs Limited Buyback – Shareholding Pattern

Click here to see the shareholding pattern of Aarti Drugs Limited.

Aarti Drugs Limited Buyback – Company Financials

Click here to see the consolidated and standalone financial report of the company.

Aarti Drugs Limited Buyback 2023 – Manager of the Buyback

Manager to this buyback offer by Aarti Drugs Limited is Inga Ventures Pvt Ltd.

Aarti Drugs Limited Buyback 2023 – Registrar of the Buyback

Registrar to this buyback offer by Aarti Drugs Limited is Link Intime India Private Ltd

Aarti Drugs Limited Buyback 2023 – Letter of Offer

Click here to read the letter of offer of this buyback offer by Aarti Drugs Limited.

Follow us on Facebook, LinkedIn, and Twitter to get the latest posts.

The post Aarti Drugs Limited Buyback 2023 – Letter of Offer, Record Date, Buyback Price appeared first on Investingly - Stock Market | Mutual Funds | IPO | NFO | NCD.